At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Dexmedetomidine +1 moredrug
Likely dose
Dexmedetomidine 10 microgramfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dexmedetomidine Versus Triamcinolone Local Injection for Pain Alleviation in Patients With Carpal Tunnel Syndrome; A Randomized Clinical Trial
In Brief
A clinical study evaluating Dexmedetomidine and Triamcinolone for Chronic Pain and Carpal Tunnel Syndrome. Completed, enrolled 60 participants across 1 site.
Detailed Summary
Carpal tunnel syndrome (CTS) is a common mononeuropathy due to entrapment of the median nerve in the carpal tunnel. a lot of modaleties are available for treatment of mild to moderate CTS.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain, Carpal Tunnel Syndrome
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedJul 2021
Enrollment StartJul 2021
Primary CompletionJul 2022
Study CompletionAug 2022
TodayJul 2026
First PostedJul 14, 2021
Enrollment StartJul 22, 2021
Primary CompletionJul 31, 2022
Study CompletionAug 1, 2022
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 5.0 years ago
Interventions
Dexmedetomidinedrug
injection of Dexmedetomidine ( 10 microgram/kg) + 10 cc saline injection nearby median nerve as hydro-dissection
Triamcinolonedrug
injection of triamcinolone ( 40 mg) + 10 cc saline injection nearby median nerve as hydro-dissection